GlassScriptPhysician profile
Marin Bautista
NPI 1528092400
$1,686.04
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $81.06 · 2020: $146 · 2021: $378 · 2022: $659 · 2023: $376 · 2024: $46.69.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $423.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $422.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $272.43 | 2019-2023 | Farxiga |
| Bayer Healthcare Pharmaceuticals INC. | $257.78 | 2022-2023 | |
| Novo Nordisk INC | $210.98 | 2021-2023 | Rybelsus, Ozempic |
| Lilly USA, LLC | $195.89 | 2019-2023 | Jardiance |
| Abbvie INC. | $185.34 | 2021-2023 | Qulipta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $130.36 | 2021-2023 | Jardiance |
| Abbott Laboratories | $77.51 | 2022-2023 | Freestyle Libre 2 |
| Amgen INC. | $73.89 | 2019-2024 | Repatha, Otezla |
| Glaxosmithkline, LLC. | $53.87 | 2020-2023 | Shingrix, Arexvy |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $46.23 | 2022 | |
| Amarin Pharma, INC. | $41.19 | 2020-2022 | |
| Saluda Medical Americas, INC. | $26.06 | 2024 | Evoke |
| Allergan, INC. | $22.45 | 2019 | |
| Idorsia Pharmaceuticals US INC | $19.73 | 2023 | Quviviq |
| Biohaven Pharmaceutical Holding Company LTD. | $19.52 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Renalytix Ai, INC. | $18.69 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $17.14 | 2020 | |
| Hologic Sales and Service, LLC | $16.98 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marin Bautista listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.